Obesity has become an epidemic in several regions globally; it may lead to
cardiovascular diseases, diabetes, and
dyslipidemia. Despite many
therapies, all bariatric procedures fail in some patients. There is a lack of literature comparing treatment effects on specific metabolic indexes. PubMed, Embase, and Cochrane Central Register of Controlled Trials were searched for relevant articles. GeMTC and R software were used to perform a network meta-analysis, draw forest plots, investigate the possibility of statistical heterogeneity, generate I2 statistics, rank probabilities, and evaluate relative effects of
surgical procedures. All analyses were based on a Bayesian consistency model. We included 35 randomized controlled trials, comprising 2198 individuals and 13 interventions. For patients with high
insulin resistance, single-anastomosis (mini-)
gastric bypass (SAGB) and sleeve
gastrectomy (SG) may be effective options, with mean differences (95% confidence intervals [CIs]) of -4.45 (-9.04 to -.34) and -4.23 (-6.74 to -2.22), respectively, compared with control groups. For patients with severe
dyslipidemia, in addition to SAGB and SG, duodenal switch (DS) may be an effective surgery, with mean differences (95% CIs) of -.97 (-1.39 to -.55), -1.98 (-3.76 to -.19), .53 (.04 to 1.04), and -.94 (-1.66 to -.16) compared with control groups in terms of
triglycerides, total
cholesterol,
high-density lipoprotein cholesterol (HDL-C), and
low-density lipoprotein cholesterol (
LDL-C) concentrations, respectively. In adult
overweight patients with or without diabetes, SAGB and SG are most effective at ameliorating
insulin resistance. SAGB,
Roux-en-Y gastric bypass + omentectomy, and DS are useful for reducing
triglycerides, total
cholesterol, and
LDL-C. SG + omentectomy elevates HDL-C concentrations best. Adjustable gastric band and
biliopancreatic diversion may not control
insulin resistance or
dyslipidemia well.